Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Costentin

Showing results (1-10 of 244) with videos related to

Pageof 25
Sort By:
Bulletin De L'Academie Nationale De Medecine|June 1, 1997
[From gene to behavior, a new way for elaborating new psychotropic agents]J Costentin
Annales Pharmaceutiques Francaises|April 27, 2004
[Physiological and neurobiological elements of food intake]J Costentin
Annales Pharmaceutiques Francaises|January 1, 1995
[Parkinson disease and the neuronal dopamine uptake complex]J Costentin
Annales Pharmaceutiques Francaises|May 3, 2000
[Pain and its main transmitters]J Costentin
L'Encephale|March 25, 2008
[Seeing a new classification of active medications in psychoses]J Costentin
L'Encephale|March 3, 2009
[A new pharmacological strategy for schizophrenia: the partial agonists of D2 dopaminergic receptors. The principle characteristics of aripiprazole]J Costentin
Therapie|July 1, 1991
[Brain dopamine receptors. Interactions between D1 and D2 receptors, and dopamine mediated behaviour]J Costentin
L'Encephale|January 1, 1979
[Modulation of dopaminergic receptor sensitivity in the central nervous system: important parameters in synaptic function regulation]J Costentin
Annales Pharmaceutiques Francaises|October 14, 2008
[Neuropsychopharmacology of delta-9-tetrahydrocannabinol]J Costentin
L'Encephale|June 1, 1991
[The pharmacologist facing the neuroleptics]J Costentin
Pageof 25

Showing results (1-10 of 244) with videos related to

Sort By:
Pageof 25
Bulletin De L'Academie Nationale De Medecine|June 1, 1997
[From gene to behavior, a new way for elaborating new psychotropic agents]J Costentin
Annales Pharmaceutiques Francaises|April 27, 2004
[Physiological and neurobiological elements of food intake]J Costentin
Annales Pharmaceutiques Francaises|January 1, 1995
[Parkinson disease and the neuronal dopamine uptake complex]J Costentin
Annales Pharmaceutiques Francaises|May 3, 2000
[Pain and its main transmitters]J Costentin
L'Encephale|March 25, 2008
[Seeing a new classification of active medications in psychoses]J Costentin
L'Encephale|March 3, 2009
[A new pharmacological strategy for schizophrenia: the partial agonists of D2 dopaminergic receptors. The principle characteristics of aripiprazole]J Costentin
Therapie|July 1, 1991
[Brain dopamine receptors. Interactions between D1 and D2 receptors, and dopamine mediated behaviour]J Costentin
L'Encephale|January 1, 1979
[Modulation of dopaminergic receptor sensitivity in the central nervous system: important parameters in synaptic function regulation]J Costentin
Annales Pharmaceutiques Francaises|October 14, 2008
[Neuropsychopharmacology of delta-9-tetrahydrocannabinol]J Costentin
L'Encephale|June 1, 1991
[The pharmacologist facing the neuroleptics]J Costentin
Pageof 25